Locust Walk Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $130M
- Underwriters
- Focus
- Healthcare, Life Sciences
- SEC Filings
- 1828522
- Public Embarc Page
- https://embarc.com/capital/spac/1828522/LWAC/locust-walk-acquisition
- IPO Ticker
- LWAC
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and DirectorChris Ehrlich
- Chief Financial OfficerDaniel Geffken
- DirectorBrian G. Atwood
- DirectorElizabeth P. Bhatt
- DirectorBarbara A. Kosacz
- DirectorCaroline M. Loewy
- AdvisorRyan Gilbert
- AdvisorShami Patel
Target Information
Information on the SPAC target for merger.
- Company
- eFFECTOR Therapeutics
- Presentation
- Investor Presentation (SEC) on 2021-05-27
- Description
- eFFECTOR is "a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors (STRIs) for the treatment of cancer."